These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7717849

  • 41. Inhibitory effects of 6-phenylhexyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation and lung tumorigenesis in rats.
    Hecht SS, Trushin N, Rigotty J, Carmella SG, Borukhova A, Akerkar S, Desai D, Amin S, Rivenson A.
    Carcinogenesis; 1996 Sep; 17(9):2061-7. PubMed ID: 8824535
    [Abstract] [Full Text] [Related]

  • 42. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
    Liu LL, Alaoui-Jamali MA, el Alami N, Castonguay A.
    Cancer Res; 1990 Mar 15; 50(6):1810-6. PubMed ID: 2306734
    [Abstract] [Full Text] [Related]

  • 43. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
    Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK.
    Cancer Res; 2002 Jan 01; 62(1):129-34. PubMed ID: 11782369
    [Abstract] [Full Text] [Related]

  • 44. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Brown B, Avalos J, Lee C, Doolittle D.
    Mutat Res; 2001 Jul 25; 494(1-2):21-9. PubMed ID: 11423342
    [Abstract] [Full Text] [Related]

  • 45. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
    Jalas JR, Ding X, Murphy SE.
    Drug Metab Dispos; 2003 Oct 25; 31(10):1199-202. PubMed ID: 12975327
    [Abstract] [Full Text] [Related]

  • 46. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats.
    Staretz ME, Koenig LA, Hecht SS.
    Carcinogenesis; 1997 Sep 25; 18(9):1715-22. PubMed ID: 9328166
    [Abstract] [Full Text] [Related]

  • 47. Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Ma B, Zarth AT, Carlson ES, Villalta PW, Upadhyaya P, Stepanov I, Hecht SS.
    Chem Res Toxicol; 2018 Jan 16; 31(1):48-57. PubMed ID: 29131934
    [Abstract] [Full Text] [Related]

  • 48. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA.
    Lacroix D, Desrochers M, Castonguay A, Anderson A.
    Carcinogenesis; 1993 Aug 16; 14(8):1639-42. PubMed ID: 8353848
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
    Wiener D, Doerge DR, Fang JL, Upadhyaya P, Lazarus P.
    Drug Metab Dispos; 2004 Jan 16; 32(1):72-9. PubMed ID: 14709623
    [Abstract] [Full Text] [Related]

  • 54. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Lee HL, Hsueh YM, Chung CJ, Pu YS, Chang LW, Hsieh DP, Liou SH, Lin P.
    Cancer Epidemiol Biomarkers Prev; 2008 Dec 16; 17(12):3390-5. PubMed ID: 19064555
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways.
    Prokopczyk B, Trushin N, Leszczynska J, Waggoner SE, El-Bayoumy K.
    Carcinogenesis; 2001 Jan 16; 22(1):107-14. PubMed ID: 11159748
    [Abstract] [Full Text] [Related]

  • 57. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, Le Marchand L.
    Int J Cancer; 2009 Nov 15; 125(10):2418-24. PubMed ID: 19598261
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H, Zhang X, Tian Y, Tang G, Liu Y, Hu Q.
    J Pharm Biomed Anal; 2012 Apr 07; 63():17-22. PubMed ID: 22366322
    [Abstract] [Full Text] [Related]

  • 60. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
    Atalla A, Maser E.
    Toxicology; 1999 Nov 29; 139(1-2):155-66. PubMed ID: 10614696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.